Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | | Jan-16 | Jan-17 | Jan-18 | Jan-19 | Jan-20 | Jan-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 0 | 251 | 152 | 321 | 495 | 544 | 277 | 782 | 888 | 709 | | 709 |
% Growth | NA | NA | -39.4% | 110.6% | 54.5% | 9.8% | -49.1% | 182.4% | 13.7% | -20.2% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | (260) | (181) | (269) | (370) | (470) | (254) | (621) | (673) | (550) | | (550) |
Gross Profit | 0 | (9) | (29) | 52 | 125 | 74 | 23 | 160 | 216 | 160 | | 160 |
% Revenue | NA | -3.4% | -19.1% | 16.1% | 25.3% | 13.6% | 8.4% | 20.5% | 24.3% | 22.5% | | 22.5% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | (0) | (2) | (2) | (3) | (1) | (1) | (1) | (1) | | (1) |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | 0 | (63) | (60) | (70) | (70) | (100) | (54) | (70) | (87) | (80) | | (80) |
Other Inc / (Exp) | 0 | (679) | 0 | (4) | (31) | (47) | (270) | (57) | (71) | (94) | | (94) |
Total Operating Exp | 0 | (742) | (60) | (76) | (103) | (150) | (324) | (128) | (159) | (175) | | (175) |
| | | | | | | | | | | | |
Operating Income | 0 | (750) | (90) | (24) | 22 | (76) | (301) | 33 | 57 | (16) | | (16) |
% Revenue | NA | -298.7% | -58.8% | -7.5% | 4.5% | -13.9% | -108.8% | 4.2% | 6.4% | -2.2% | | -2.2% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | 0 | (7) | (29) | (31) | (35) | (35) | (37) | | (37) |
Pre-tax Income | 0 | (750) | (90) | (24) | 15 | (105) | (332) | (3) | 22 | (52) | | (52) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 0 | (0) | (0) | (0) | (1) | 9 | (0) | (1) | (3) | (1) | | (1) |
Net Income to Company | 0 | (750) | (90) | (24) | 14 | (96) | (332) | (3) | 19 | (53) | | (53) |
% Margin | NA | -298.7% | -58.9% | -7.5% | 2.9% | -17.7% | -120.0% | -0.4% | 2.2% | -7.5% | | -7.5% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 0 | (750) | (90) | (24) | 14 | (96) | (332) | (3) | 19 | (53) | | (53) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 0 | (750) | (90) | (24) | 14 | (96) | (332) | (3) | 19 | (53) | | (53) |
% Margin | NA | -298.7% | -58.9% | -7.5% | 2.9% | -17.7% | -120.0% | -0.4% | 2.2% | -7.5% | | -7.5% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.00 | 0.00 | (22.29) | (6.00) | 3.58 | (21.42) | (51.11) | (0.27) | 1.23 | (3.27) | | (3.27) |
Diluted EPS (Continuing Ops) | 0.00 | 0.00 | (22.30) | (6.00) | 3.55 | (21.61) | (51.11) | (0.27) | 1.22 | (3.27) | | (3.27) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.00 | 0.00 | 4.02 | 4.02 | 4.02 | 4.50 | 6.50 | 11.30 | 15.60 | 16.20 | | 16.20 |
WA Diluted Shares Out. | 0.00 | 0.00 | 4.02 | 4.02 | 4.04 | 4.50 | 6.50 | 11.30 | 15.70 | 16.20 | | 16.20 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 0 | (750) | (90) | (24) | 15 | (105) | (332) | (3) | 22 | (52) | | (52) |
Addback: Net Interest Expense | 0 | 0 | 0 | 0 | 7 | 29 | 31 | 35 | 35 | 37 | | 37 |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Depreciation & Amortization | 0 | 42 | 36 | 33 | 41 | 65 | 61 | 57 | 73 | 94 | | 94 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 40 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 310 | 0 | 0 | 0 | 47 | 28 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 330 | 0 | 0 | 0 | 0 | 180 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 39 | 0 | 4 | 31 | 0 | (40) | 0 | (2) | 0 | | 0 |
Adjusted EBITDA | 0 | (30) | (54) | 13 | 94 | 36 | (32) | 89 | 128 | 79 | | 79 |
% Margin | NA | -12.0% | -35.2% | 4.0% | 19.0% | 6.6% | -11.4% | 11.4% | 14.4% | 11.1% | | 11.1% |
| | | | | | | | | | | | |
Adjusted EBIT | 0 | (72) | (90) | (20) | 53 | (29) | (93) | 33 | 55 | (15) | | (15) |
% Margin | NA | -28.5% | -58.8% | -6.4% | 10.6% | -5.3% | -33.6% | 4.2% | 6.2% | -2.2% | | -2.2% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 0 | (750) | (90) | (24) | 14 | (96) | (332) | (3) | 19 | (53) | | (53) |
Addback: Unusual Items | 0 | 679 | 0 | 4 | 31 | 47 | 208 | 0 | (2) | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | 0 | (176) | 0 | (1) | (8) | (12) | (54) | 0 | 0 | (0) | | (0) |
Adjusted Net Income | 0 | (248) | (90) | (21) | 37 | (62) | (178) | (3) | 18 | (53) | | (53) |
% Margin | NA | -98.8% | -58.9% | -6.7% | 7.5% | -11.3% | -64.4% | -0.4% | 2.0% | -7.5% | | -7.5% |